Mabaloxavir vs. oseltamivir: A careful comparison of influenza treatments
When the flu strikes, the feeling of fatigue, high fever, and splitting headache is really uncomfortable. Fortunately, there are drugs such as mabaloxavir and oseltamivir that can help us fight the flu virus and relieve symptoms. But what are the differences between these two drugs? Today, let's take a deeper look.
1. Mechanism of action: different antiviral “moves”
Mabaloxavir is like an "intelligence expert" who has penetrated deep into the enemy. As a cap-dependent endonuclease inhibitor, it precisely targets the cap-dependent endonuclease of influenza virus. When viruses invade human cells, in order to multiply in large numbers, they need to obtain the "cap" structure of host cell mRNA to start the synthesis of their own mRNA. Mabaloxavir can specifically inhibit this endonuclease, cleverly blocking the process of the virus obtaining the "cap" structure, making it impossible for the virus to synthesize its own mRNA, cutting off the path of virus replication and transmission from the source, thereby achieving the purpose of treating influenza.
Oseltamivir is like a "guard" standing at the "exit" of the cell. It is a neuraminidase inhibitor. Newly formed virus particles need the help of neuraminidase to be released from the surface of infected cells, and then infect more cells and expand the "virus power". Oseltamivir inhibits the activity of neuraminidase, preventing the release of the virus from infected cells, successfully blocking the spread of the virus in the body, and protecting our bodies from further damage by the virus.
2. Applicable groups: "protected objects" with different focuses
Mabaloxavir mainly focuses on the "scope of protection" for patients aged 12 years and above with simple influenza A and B. For patients in this age group, the use of mabaloxavir within 48 hours after the onset of influenza symptoms often achieves good results, effectively relieves symptoms and shortens the course of the disease.
The "protection range" of oseltamivir is even wider, covering almost all age groups, including adults, children, and even some special groups, such as pregnant women, the elderly, and people with chronic underlying diseases. Timely use of oseltamivir on the first or second day of flu symptoms (ideally within 36 hours) can not only treat influenza, but also play a preventive role for those at high risk of influenza infection.
3. Medication method: different "drug administration strategies"
Mabaloxavir adopts a simple and efficient "single-dose administration strategy". It is in the form of tablets. For patients weighing ≥40kg, only 40mg is needed for a single oral administration; for patients weighing between 20-40kg, 20mg is needed for a single oral administration. This administration method greatly improves the patient's medication compliance, and there is no need to worry about missing or taking the wrong dose due to multiple doses.
Oseltamivir requires patients to follow a certain course of treatment. Its common dosage forms are capsules and granules. When treating influenza, the recommended oral dose for adults and adolescents aged 13 and above is 75 mg each time, twice a day, for a course of 5 days; children need to calculate the dose based on their weight, and different weight ranges correspond to different dosages. In contrast, the course of treatment for oseltamivir is longer, requiring patients to more strictly adhere to the medication time and dosage.
IV. Treatment effect: "treatment performance" with its own highlights
Mabaloxavir has the advantage of single-dose administration, which can take effect quickly and has a short treatment course. After taking Mabaloxavir, many patients can significantly relieve fever symptoms and significantly shorten the course of influenza, allowing patients to recover faster.
Although oseltamivir needs to be taken continuously for several days according to the course of treatment, it can also effectively relieve influenza symptoms and shorten the course of the disease. However, due to the long course of treatment, patients need to strictly abide by the medication time and dosage to ensure that the drug can fully exert its therapeutic effect.
5. Adverse reactions: different "physical reactions"
Mabaloxavir is generally well tolerated, with common adverse reactions including diarrhea, nausea, bronchitis, headache, etc., but these symptoms are usually mild and self-limiting, which means they will resolve on their own after a period of time. Only a very small number of patients may experience serious adverse reactions such as allergic reactions and abnormal liver function.
The most common adverse reaction of oseltamivir is gastrointestinal discomfort, such as nausea, vomiting, abdominal pain, etc. These symptoms are mostly transient and can be relieved by themselves after continuing to take the drug or stopping the drug. A small number of patients may experience neurological symptoms such as dizziness, headache, insomnia, fatigue, etc., and a very small number of patients may also experience allergic reactions.
Mabaloxavir and oseltamivir each have their own characteristics and advantages in the treatment of influenza. When facing influenza, we cannot blindly choose drugs, but should comprehensively consider factors such as the patient's age, condition, and physical condition, and use drugs rationally under the professional guidance of doctors, so that the drugs can play the greatest role and help us defeat influenza as soon as possible.
--------------------------------
Welcome to add customer service to get new customer discount
Customer Service 1 ： AobMedical
Customer Service 2 ： Aob202404
Asakusa makeup: +81 8070566715 